Heyholder
‹ Activism Filings

Icure Pharmaceutical Incorporation 15-day patch manufacturing suspension, KRW 13.9 billion in affected sales

Icure Pharmaceutical Incorporation· Material Event Report

AI summary · Not investment advice

A 15-day patch manufacturing suspension starts 2026.11.18, covering KRW 13.9 billion in sales, 16.77% of revenue.

Revenue of suspended business

KRW 13.9 billion

2025 sales amount of the company's patch products

Key facts

Suspended business
Suspension of patch (adhesive plaster) manufacturing operations
Board resolution date
Nov 6, 2026Date the administrative disposition notice was received

Commentary

AI commentary · Not investment advice

What happened

iCure received an order to stop manufacturing patch-type products (adhesive patches) for 15 days. The suspension runs from 2026.11.18 to 2026.12.02. The sales tied to this order total KRW 13.89 billion.

In the company's terms

This equals 16.77% of the company's recent total sales of KRW 82.84 billion.

What changes for shareholders

The suspension starts on 2026.11.18, and this schedule is confirmed. The board of directors made its resolution on 2026.11.06.

How is this disclosure for shareholders?

All 1

Good for shareholders0%
Not sure0%
Bad100%

Comments

No comments yet

Comments from shareholders will appear here.